The company develops innovative technologies for rapid and accurate microbiology testing. With its patented Molecular Culture® platform, bacteria and fungi can be identified within hours instead of the days required by traditional culture methods. By combining advanced molecular technology with AI and data analysis, inbiome helps hospitals and laboratories start the right treatment faster, reduce complications, and combat antibiotic resistance. The company collaborates with leading European and American hospitals and research institutions to accelerate the future of infection diagnostics.